Sample | FRAP (mg AAE 100 g− 1) | CUPRAC (mg AAE 100 g− 1) | TRC (mg QE 100 g− 1) | DPPH (% inhibition) | ILP (% inhibition) |
---|---|---|---|---|---|
PNB | 132.31 ± 4.10e,B | 227.68 ± 11.42e,B | 258.69 ± 9.50d,A | 40.93 ± 1.67d,B | 44.94 ± 0.79f,B |
C1 | 133.32 ± 12.30e | 240.93 ± 17.23e | 159.66 ± 9.70f | 32.70 ± 0.70e | 46.63 ± 2.21e |
C2 | 160.73 ± 14.81d | 312.44 ± 22.16d | 219.08 ± 12.02e | 43.82 ± 0.63c | 52.43 ± 1.15d |
C3 | 341.08 ± 15.47c | 575.16 ± 14.92c | 483.85 ± 5.20c | 41.31 ± 0.76d | 53.98 ± 2.11c |
C4 | 504.41 ± 17.47b | 1020.95 ± 24.44b | 889.28 ± 31.02b | 65.99 ± 0.69b | 68.06 ± 0.74b |
C5 | 747.43 ± 23.36a | 1312.19 ± 66.00a | 1393.73 ± 14.21a | 76.45 ± 0.89a | 73.89 ± 1.21a |
I1 | 155.33 ± 5.72 A | 280.92 ± 6.83 A | 202.74 ± 4.12B | 42.64 ± 0.40 A | 46.62 ± 0.90 A |
I2 | 99.75 ± 8.83D | 147.97 ± 15.89 C | 15.97 ± 1.84 F | 13.82 ± 0.82D,E | 21.69 ± 0.72E |
I3 | 96.66 ± 3.81D | 145.72 ± 8.57 C | 41.30 ± 18.05E | 12.71 ± 0.83E | 31.22 ± 2.31 C |
I4 | 89.85 ± 6.49D | 134.98 ± 3.31 C | 83.79 ± 14.71D | 15.60 ± 0.99D | 30.03 ± 0.53D |
I5 | 107.31 ± 2.13 C | 132.14 ± 25.86 C | 95.73 ± 6.17 C | 26.48 ± 0.80 C | 33.78 ± 1.17 C |